Company intelligence / Profile preview
Algen Biotechnologies
San Francisco, California, United Statesalgenbio.com ↗
- Ownership
- Private
- Development stage
- Preclinical
01
Overview
Algen Biotechnologies has developed a proprietary CRISPR-based functional genomics platform combined with advanced AI to identify novel therapeutic targets by reverse engineering disease trajectories at single-cell resolution. Their lead programs are in preclinical development, focusing on first-in-class drugs that modulate disease-driving RNA messages. The company partners with major pharmaceutical companies to deploy its technology across multiple indications including cancer and inflammation.
- Therapeutic areas
- OncologyImmunologyOther
- Modalities
- Gene modulation (CRISPR-based)RNA-targeting therapeuticsAI-driven drug discovery
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →03
Partnerships
Partners with leading pharmaceutical companies on its flagship next-generation CRISPR-based platform; specific partners not named publicly as of latest disclosures.
Beyond the preview
Go deeper on Algen Biotechnologies.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Algen Biotechnologies.